/

Tessera Therapeutics

Develops gene writing technology to treat and cure diseases.

BiotechnologyLife Sciences tesseratherapeutics.com ↗

Company facts

Founded: 2018
Employees: 300
Headquarters: United States
Type: Private
Funding: Series D · $200M · 2025